Analytical Data
-
Gene name
PH1536
- Application
-
Alternative Names
/
-
Species
Pyrococcus horikoshii
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O59205
-
Expression Region
1-142aa
-
Molecular Weight
24.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PH1536 is a recombinant protein that has gained attention in the field of biomedical research due to its potential applications in therapeutic interventions and biological studies. The background of its study stems from the increasing demand for novel proteins that can modulate biological pathways for treating diseases, particularly those related to immune response and cancer. This protein is derived from a specific expression system, allowing for high-yield production and the ability to manipulate its structure for desired biological activity. Researchers have focused on elucidating the protein’s mechanisms of action, stability, and interaction with cellular components to better understand its role in physiological processes. Furthermore, studies have aimed at optimizing the protein for various applications, including drug development and vaccine formulation. As advancements in recombinant DNA technology continue to evolve, PH1536 represents a promising candidate for further exploration, providing insights that could lead to innovative therapeutic strategies. The ongoing research on PH1536 not only highlights its potential benefits but also contributes to the broader understanding of protein functionality in biological systems, paving the way for future advancements in medical science.
